Search results
Andrew J. Conrad is an American geneticist who heads Verily, a life sciences division of Alphabet Inc. As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.
Andy Conrad Having recently led groundbreaking work in the field of diagnostics as a molecular biologist and Chief Scientist at LabCorp, Andy joined the Google X team with the audacious goal to deliver a “10x change” in healthcare.
Andrew Conrad, PhD, is the Chief Executive Officer, Chairman and Founder of Verily where he oversees an integrated team of engineers, scientists, designers, ...
Dr. Conrad is the Head of Google Life Sciences and a member of the Precision Medicine Initiative Working Group of the Advisory Committee to the Director. He has a background in genetics, biotechnology, and healthcare innovation.
Andrew Conrad is a healthcare entrepreneur and investor who leads Verily, a subsidiary of Alphabet. He also serves on the board of Genalyte, a biotech company, and advises SandboxAQ, an edtech startup.
22 de dic. de 2021 · Gillett, who joined Verily as COO in 2020, will work with CEO Andy Conrad and other executives to grow the Alphabet offshoot. Conrad will focus on long-term strategy, business development and partnerships.
13 de oct. de 2021 · Learn about Andrew Conrad, the leader of Alphabet's life sciences division Verily, and his achievements in genetics, health, and business. Discover his personal life, net worth, and properties, from Malibu to Lanai.
